About Immunocellular Therapy
Immune cell therapy is an emerging treatment to cancer. Tumor cells can develop drug-resistance even after long time chemotherapy or targeted therapy, leading to tumor growth and limiting the effectiveness of these treatments. Immune cellular therapy utilizes patients’ immune cells to target and fight tumors, offering fewer side effects and improved quality of life. It has currently become a new therapeutic option for cancer treatment.
READ MORE
Immunocellular Therapy Treatment Process
Lukas Biomedical’s anti-cancer immunocellular therapy using "Memory T Cells" involves a simple procedure that requires only a single blood draw to complete the entire treatment. This approach lets patients maintain a good quality of life and serves as a beneficial treatment option for cancer patients.
READ MORE
Clinical Trials for Liver Cancer Drug Development
We obtained orphan drug designation (ODD) from the U.S. FDA for liver cancer in 2018, and received approval for Phase II clinical trials from the FDA in 2021. We also secured approval for Phase II clinical trials from Taiwan's Ministry of Health and Welfare (TFDA) and partnered with 13 medical centers in Taiwan.
READ MORE
Head neck cancer new drug development progress
Clinical trial for head neck cancer (Project ID: LUKACT-01-01; Project title: Study on the use of activated T cells for the treatment of locally advanced head neck squamous cell carcinoma after surgery section and combined radiotherapy and chemotherapy) was approved by TFDA in 2018.
READ MORE
Compassionate Treatment
"Compassionate Treatment", simply put, is a treatment aimed at severely ill patients, using therapies that have not yet been officially approved by the regulatory authorities.
READ MORE
